Sesen Bio, Inc. (34)

Browse by Contract Category

Contracts

License Agreement, effective January 13, 2003, as amended and restated on October 14, 2015, by and between The University of Zurich and Viventia Bio Inc (Filed With SEC on May 9, 2022)
Form of PSU Award Agreement for Retention Awards (Filed With SEC on February 28, 2022)
Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Filed With SEC on February 28, 2022)
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)
Amendment No. 1 to the Sesen Bio, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on May 3, 2021)
Form of RSU Award Agreement for Retention Awards (Filed With SEC on February 28, 2022)
Amendment No (Filed With SEC on June 1, 2021)
Amendment No. 2 to the Sesen Bio, Inc. 2014 Stock Incentive Plan (Filed With SEC on May 3, 2021)
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 15, 2021)
Amendment No. 2 to the Open Market Sale Agreement (Filed With SEC on February 17, 2021)
Exclusive License Agreement, dated July (Filed With SEC on November 9, 2020)
Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Filed With SEC on March 16, 2020)
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)
Open Market Sale AgreementSM, dated November 29, 2019, by and between Sesen Bio, Inc. and Jefferies LLC (Filed With SEC on November 29, 2019)
Employment Agreement, dated July 26, 2019, by and between Mark R. Sullivan and Sesen Bio, Inc (Filed With SEC on November 12, 2019)
Stock Option Award Agreement, dated August 1, 2019, by and between Sesen Bio, Inc. and Monica Forbes (Filed With SEC on November 12, 2019)
Amendment to Securities Purchase Agreement, dated October 28, 2019, by and among Sesen Bio, Inc. and the undersigned parties thereto (Filed With SEC on October 29, 2019)
Form of 2018 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
Form of 2018 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
Form of 2017 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
Form of 2017 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
Press Release, dated August 26, 2019 (Filed With SEC on August 26, 2019)
Form of Indemnification Agreement, by and between Sesen Bio, Inc. and each of its directors and executive officers (Filed With SEC on August 26, 2019)
Employment Agreement, dated August 26, 2019, by and between Monica Forbes and Sesen Bio, Inc (Filed With SEC on August 26, 2019)
Consulting Agreement, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)
Separation and General Release, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)
Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on August 8, 2019)
2014 Stock Incentive Plan, as amended (Filed With SEC on June 25, 2019)
Form of Warrant (Filed With SEC on June 19, 2019)
Underwriting Agreement, dated June 19, 2019 (Filed With SEC on June 19, 2019)
Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on May 10, 2019)
Stock Option Award Agreement, dated December 3, 2018, by and between Sesen Bio, Inc. and Dennis Kim, M.D (Filed With SEC on March 1, 2019)
Master Bioprocessing Services Agreement, dated October 4, 2018, between Sesen Bio, Inc. and FUJIFILM Diosynth Biotechnologies U.S.A., Inc (Filed With SEC on March 1, 2019)
Stock Option Award Agreement, dated August 7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M (Filed With SEC on March 1, 2019)